Barchart.com
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Relay Therapeutics Inc (RLAY)

Relay Therapeutics Inc (RLAY)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.72 -0.27 (-9.03%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.72 unch (unch) 16:33 ET
News & Headlines for Fri, Mar 28th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates GlobeNewswire - Wed Feb 26, 3:05PM CST

RLAY : 2.72 (-9.03%)
Relay Therapeutics to Participate in Two Upcoming Investor Conferences GlobeNewswire - Mon Feb 24, 3:05PM CST

RLAY : 2.72 (-9.03%)
Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025 GlobeNewswire - Wed Feb 19, 3:05PM CST

RLAY : 2.72 (-9.03%)
Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Tue Jan 7, 3:05PM CST

RLAY : 2.72 (-9.03%)
Relay Therapeutics Reports Promising Interim Data for RLY-2608 in 2L PI3Kα-Mutated Metastatic Breast Cancer Quiver Quantitative, Inc. - Wed Dec 11, 2024

Relay Therapeutics reports positive interim data for RLY-2608 in metastatic breast cancer, supporting a pivotal study in 2025.Quiver AI SummaryRelay Therapeutics, Inc. has announced updated interim clinical...

RLAY : 2.72 (-9.03%)
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival GlobeNewswire - Wed Dec 11, 2024

RLAY : 2.72 (-9.03%)
Relay Therapeutics to Present Updated Clinical Data for RLY-2608 at San Antonio Breast Cancer Symposium Quiver Quantitative, Inc. - Tue Dec 10, 2024

Relay Therapeutics will present updated clinical data for RLY-2608 in advanced breast cancer at the San Antonio Symposium.Quiver AI SummaryRelay Therapeutics, a clinical-stage precision medicine company,...

RLAY : 2.72 (-9.03%)
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium GlobeNewswire - Mon Dec 9, 2024

RLAY : 2.72 (-9.03%)
Relay Therapeutics and Elevar Therapeutics Announce Global Licensing Agreement for Lirafugratinib, a Potential Best-in-Class FGFR2 Inhibitor Quiver Quantitative, Inc. - Tue Dec 3, 2024

Elevar Therapeutics secures global rights to develop lirafugratinib, a promising FGFR2 inhibitor, with potential milestone payments for Relay Therapeutics.Quiver AI SummaryRelay Therapeutics and Elevar...

RLAY : 2.72 (-9.03%)
Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors GlobeNewswire - Tue Dec 3, 2024

RLAY : 2.72 (-9.03%)
Relay Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Thu Nov 7, 2024

RLAY : 2.72 (-9.03%)
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights GlobeNewswire - Wed Nov 6, 2024

RLAY : 2.72 (-9.03%)
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 GlobeNewswire - Wed Oct 30, 2024

RLAY : 2.72 (-9.03%)
Why Relay Therapeutics Plummeted by Nearly 14% Today Motley Fool - Wed Sep 11, 2024

Investors weren't happy with the company's latest effort at capital-raising.

GS : 543.12 (-2.83%)
BAC : 41.25 (-3.08%)
SF : 93.87 (-3.30%)
RLAY : 2.72 (-9.03%)
Healthcare - stethoscope-with-injection-protective-mask-lying-over-medical-chart-SBI-300904603
5 Biotech Stocks With 26% Upside Potential or More Barchart - Thu Mar 7, 2024

As biotech stocks swing back into favor on Wall Street, here's a look at five picks that could deliver significant gains, according to analysts.

$SPX : 5,580.94 (-1.97%)
NVO : 69.30 (-1.23%)
BIIB : 138.37 (-1.40%)
KNSA : 23.09 (-1.16%)
SWTX : 47.41 (-0.17%)
RLAY : 2.72 (-9.03%)
ADPT : 7.67 (-6.69%)
GS : 543.12 (-2.83%)
Author
Unlocking AI investment opportunities in healthcare MarketBeat - Thu Nov 16, 2023

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

INTC : 22.71 (-3.85%)
NVDA : 109.67 (-1.58%)
RXRX : 5.81 (-2.68%)
RLAY : 2.72 (-9.03%)
EXAI : 4.84 (+3.20%)
RENB : 0.5788 (-10.89%)
BTAI : 2.12 (-8.23%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028 FinancialNewsMedia - Fri May 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END

ONCY : 0.6000 (-2.31%)
ONC.TO : 0.85 (-5.56%)
PFE : 25.21 (+0.80%)
OCEA : 0.0636 (-18.46%)
NVS : 112.57 (+1.05%)
RLAY : 2.72 (-9.03%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028 PR Newswire - Fri May 26, 2023

/PRNewswire/ -- Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has spread to the other parts of the body from...

ONC.TO : 0.85 (-5.56%)
ONCY : 0.6000 (-2.31%)
PFE : 25.21 (+0.80%)
OCEA : 0.0636 (-18.46%)
NVS : 112.57 (+1.05%)
RLAY : 2.72 (-9.03%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer FinancialNewsMedia - Fri Mar 24, 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2023 – USA News Group  –  Treatments for various forms of breast cancer continue to evolve, with several new...

BCTX : 3.97 (-1.73%)
ONCY : 0.6000 (-2.31%)
ONC.TO : 0.85 (-5.56%)
CTMX : 0.6282 (+1.88%)
BCT.TO : 5.67 (-2.41%)
RLAY : 2.72 (-9.03%)
HOLX : 61.32 (-1.60%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer PR Newswire - Fri Mar 24, 2023

/PRNewswire/ -- USA News Group - Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in...

BCTXW : 0.1049 (+0.38%)
ONC.TO : 0.85 (-5.56%)
BCT.TO : 5.67 (-2.41%)
ONCY : 0.6000 (-2.31%)
CTMX : 0.6282 (+1.88%)
BCTX : 3.97 (-1.73%)
RLAY : 2.72 (-9.03%)
HOLX : 61.32 (-1.60%)

Barchart Exclusives

Trump Tariffs, Tesla Deliveries and Other Key Things to Watch this Week Barchart - Sun Mar 30, 6:38PM CDT
The S&P 500 suffered more selling on Friday after a hot inflation report and weak consumer sentiment spooked investors. Here are 5 things to watch this week in the Market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies
Wed, Apr 02, 2025 5:00 PM UTC
Reserve Your Spot